Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00221754 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pravastatin and Protease Inhibitors in HIV-infected Patients

StatusCompleted
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Interventions: Pravastatin (drug) (Drug) to Placebo (Drug), Pravastatin (drug) (Drug) Study arms: 0 to 2v5 Show all 2 changesShow less
    • Study arms: 0 to 2
  2. Enrollment target: 60 to 21 Primary endpoint revised · Study title expanded, about 3 wordsv4 Show all 3 changesShow less
    • Primary endpoint revised
    • Study title expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  3. Trial status: Terminated to Completed Secondary endpoints revised (4)v3 Show all 2 changesShow less
    • Secondary endpoints revised (4)

    See this version in full on ClinicalTrials.gov ↗

  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To assess the use of pravastatin in hypercholesterolemic HIV-infected patients treated with protease inhibitors in a randomised double blind study.
Trial Details
NCT Number NCT00221754
Lead Sponsor University Hospital, Bordeaux
Collaborators: Ministry of Health, France
Conditions HIV Infection, Hypercholesterolemia
Enrollment 21 participants
Start Date
Study Completion (estimated)
Updated on ClinicalTrials.gov